13G Filing: Nine Ten Partners and Mesa Laboratories Inc (MLAB)
...... (read more)
Mesa Laboratories Inc (MLAB)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 92,206 | $11,461 | -25% | 3.98% |
| 2. | Royce & Associates Chuck Royce | 78,762 | $9,790 | +3% | 0.06% |
| 3. | Navellier & Associates Louis Navellier | 1,832 | $228 | -2% | 0.04% |
| 4. | Renaissance Technologies Jim Simons | 78,600 | $9,770 | -7% | 0.01% |
| 5. | AQR Capital Management Cliff Asness | 3,262 | $405 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $109.54 | 150 | Director | 78,848 | 2015-09-22 | Filing | |
| $33.59 | 1,000 | Officer | 12,275 | 2011-08-29 | Filing | |
| $30.95 | 450 | Director | 8,450 | 2011-06-13 | Filing | |
| $30.00 | 300 | Director | 8,000 | 2011-06-09 | Filing | |
| $29.00 | 10,000 | Director | 200,000 | 2011-03-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $144.01 | 5,000 | Director | 68,521 | 2018-03-14 | Filing | |
| $138.00 | 2,123 | Director | 71,148 | 2018-02-16 | Filing | |
| $138.00 | 1,877 | Director | 73,271 | 2018-02-15 | Filing | |
| $132.27 | 3,000 | Director | 77,869 | 2018-02-08 | Filing | |
| $130.16 | 1,000 | Director | 42,366 | 2017-08-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,484 | $369 | 0.15% | |
| 2. | 5,036 | $748 | 0.03% | |
| 3. | 4,650 | $690 | 0.01% | |
| 4. | 12,596 | $1,870 | 0.01% | |
| 5. | 2,155 | $320 | 0% |
News See All
Insider Buying at 3 Companies Amid Historically Low Insider Buying, Plus Insider Selling at 2 Companies
According to research firm TrimTabs, the dollar volume of insider buying from early-October through the end of last week stood at about $110 million, representing the lowest monthly total in the past...... (read more)
Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March. HBIO shareholders have witnessed an increase in activity from the world's largest hedge funds in recent months...... (read more)
This Metric Says You Are Smart to Sell STAAR Surgical Company (STAA)
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds' portfolio at the end of March. STAA shareholders have witnessed a decrease in enthusiasm from smart money in recent months. There were 7 hedge...... (read more)
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately. There were 8 hedge funds in our...... (read more)
Alphatec Holdings Inc (ATEC): Insiders Are Buying, Should You?
Alphatec Holdings Inc (NASDAQ:ATEC) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. ATEC shareholders have witnessed an increase in hedge fund interest in recent months. There...... (read more)
AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets. A couple of the most underrated are hedge fund and insider trading sentiment. At Insider...... (read more)
Should You Avoid Alphatec Holdings Inc (ATEC)?
Is Alphatec Holdings Inc (NASDAQ:ATEC) a superb stock to buy now? The best stock pickers are taking a pessimistic view. The number of long hedge fund positions stayed the same which is a slightly negative...... (read more)
Billionaire Hedge Funds
